13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      ATP inhibits Ins(1,4,5) P 3-evoked Ca 2+ release in smooth muscle via P2Y 1 receptors

      research-article
      * , ,
      Journal of cell science
      ATP, Smooth muscle, Ins(1,4,5)P3, Calcium

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          Adenosine 5′-triphosphate (ATP) mediates a variety of biological functions following nerve-evoked release, via activation of either G-protein-coupled P2Y- or ligand-gated P2X receptors. In smooth muscle, ATP, acting via P2Y receptors (P2YR), may act as an inhibitory neurotransmitter. The underlying mechanism(s) remain unclear, but have been proposed to involve the production of inositol 1,4,5-trisphosphate [Ins(1,4,5) P 3] by phospholipase C (PLC), to evoke Ca 2+ release from the internal store and stimulation of Ca 2+-activated potassium (K Ca) channels to cause membrane hyperpolarization. This mechanism requires Ca 2+ release from the store. However, in the present study, ATP evoked transient Ca 2+ increases in only ~10% of voltage-clamped single smooth muscle cells. These results do not support activation of K Ca as the major mechanism underlying inhibition of smooth muscle activity. Interestingly, ATP inhibited Ins(1,4,5) P 3-evoked Ca 2+ release in cells that did not show a Ca 2+ rise in response to purinergic activation. The reduction in Ins(1,4,5) P 3-evoked Ca 2+ release was not mimicked by adenosine and therefore, cannot be explained by hydrolysis of ATP to adenosine. The reduction in Ins(1,4,5) P 3-evoked Ca 2+ release was, however, also observed with its primary metabolite, ADP, and blocked by the P2Y 1R antagonist, MRS2179, and the G protein inhibitor, GDPβS, but not by PLC inhibition. The present study demonstrates a novel inhibitory effect of P2Y 1R activation on Ins(1,4,5) P 3-evoked Ca 2+ release, such that purinergic stimulation acts to prevent Ins(1,4,5) P 3-mediated increases in excitability in smooth muscle and promote relaxation.

          Related collections

          Most cited references75

          • Record: found
          • Abstract: found
          • Article: not found

          International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.

          There have been many advances in our knowledge about different aspects of P2Y receptor signaling since the last review published by our International Union of Pharmacology subcommittee. More receptor subtypes have been cloned and characterized and most orphan receptors de-orphanized, so that it is now possible to provide a basis for a future subdivision of P2Y receptor subtypes. More is known about the functional elements of the P2Y receptor molecules and the signaling pathways involved, including interactions with ion channels. There have been substantial developments in the design of selective agonists and antagonists to some of the P2Y receptor subtypes. There are new findings about the mechanisms underlying nucleotide release and ectoenzymatic nucleotide breakdown. Interactions between P2Y receptors and receptors to other signaling molecules have been explored as well as P2Y-mediated control of gene transcription. The distribution and roles of P2Y receptor subtypes in many different cell types are better understood and P2Y receptor-related compounds are being explored for therapeutic purposes. These and other advances are discussed in the present review.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Pathophysiology and therapeutic potential of purinergic signaling.

            The concept of a purinergic signaling system, using purine nucleotides and nucleosides as extracellular messengers, was first proposed over 30 years ago. After a brief introduction and update of purinoceptor subtypes, this article focuses on the diverse pathophysiological roles of purines and pyrimidines as signaling molecules. These molecules mediate short-term (acute) signaling functions in neurotransmission, mechanosensory transduction, secretion and vasodilatation, and long-term (chronic) signaling functions in cell proliferation, differentiation, and death involved in development and regeneration. Plasticity of purinoceptor expression in pathological conditions is frequently observed, including an increase in the purinergic component of autonomic cotransmission. Recent advances in therapies using purinergic-related drugs in a wide range of pathological conditions will be addressed with speculation on future developments in the field.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology.

              The many components of G-protein-coupled receptor (GPCR) signal transduction provide cells with numerous combinations with which to customize their responses to hormones, neurotransmitters, and pharmacologic agonists. GPCRs function as guanine nucleotide exchange factors for heterotrimeric (alpha, beta, gamma) G proteins, thereby promoting exchange of GTP for GDP and, in turn, the activation of 'downstream' signaling components. Recent data indicate that individual cells express mRNA for perhaps over 100 different GPCRs (out of a total of nearly a thousand GPCR genes), several different combinations of G-protein subunits, multiple regulators of G-protein signaling proteins (which function as GTPase activating proteins), and various isoforms of downstream effector molecules. The differential expression of such protein combinations allows for modulation of signals that are customized for a specific cell type, perhaps at different states of maturation or differentiation. In addition, in the linear arrangement of molecular interactions involved in a given GPCR-G-protein-effector pathway, one needs to consider the localization of receptors and post-receptor components in subcellular compartments, microdomains, and molecular complexes, and to understand the movement of proteins between these compartments. Co-localization of signaling components, many of which are expressed at low overall concentrations, allows cells to tailor their responses by arranging, or spatially organizing in unique and kinetically favorable ways, the molecules involved in GPCR signal transduction. This review focuses on the role of lipid rafts and a subpopulation of such rafts, caveolae, as a key spatial compartment enriched in components of GPCR signal transduction. Recent data suggest cell-specific patterns for expression of those components in lipid rafts and caveolae. Such domains likely define functionally important, cell-specific regions of signaling by GPCRs and drugs active at those GPCRs.
                Bookmark

                Author and article information

                Journal
                0052457
                4592
                J Cell Sci
                J. Cell. Sci.
                Journal of cell science
                0021-9533
                1477-9137
                23 August 2017
                16 August 2012
                01 November 2012
                28 November 2017
                : 125
                : Pt 21
                : 5151-5158
                Affiliations
                Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow G4 0RE, UK
                Author notes
                [* ]Author for correspondence ( d.macmillan@ 123456strath.ac.uk )
                Article
                EMS73875
                10.1242/jcs.108498
                5704898
                22899721
                f30b08e6-5646-430f-bb69-625cfedb854d

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share Alike License ( http://creativecommons.org/licenses/by-nc-sa/3.0/), which permits unrestricted non-commercial use, distribution and reproduction in any medium provided that the original work is properly cited and all further distributions of the work or adaptation are subject to the same Creative Commons License terms.

                History
                Categories
                Article

                Cell biology
                atp,smooth muscle,ins(1,4,5)p3,calcium
                Cell biology
                atp, smooth muscle, ins(1,4,5)p3, calcium

                Comments

                Comment on this article